Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing innovative oral drugs for patients with serious diseases and disorders, such as obesity and insomnia. We have a diverse portfolio of drug candidates, both proprietary and partnered. Our lead proprietary drug candidate, lorcaserin hydrochloride, is intended for the treatment of obesity and is being evaluated in a Phase 3 clinical program.